An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus. [electronic resource]
Producer: 20110131Description: 765-80 p. digitalISSN:- 1179-2027
- Adult
- Aged
- Allylamine -- administration & dosage
- Cardiovascular Diseases -- economics
- Cholesterol, LDL -- blood
- Colesevelam Hydrochloride
- Cost-Benefit Analysis -- methods
- Databases, Factual
- Diabetes Complications -- economics
- Diabetes Mellitus, Type 2 -- blood
- Drug Therapy, Combination -- economics
- Female
- Glycated Hemoglobin -- metabolism
- Health Care Costs
- Humans
- Hypercholesterolemia -- blood
- Insulin -- administration & dosage
- Male
- Metformin -- administration & dosage
- Middle Aged
- Models, Economic
- Randomized Controlled Trials as Topic
- Risk
- Sulfonylurea Compounds -- administration & dosage
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.